Posted: 26 Apr 2018 | 12:13
The HPC-Europa3 Transnational Access programme includes access to world-class HPC systems and scientific collaboration with host researchers in any field. If you want to find out more about the programme then this video, originally part of the ARCHER series of webinars, is an excellent starting point.
Posted: 21 Apr 2018 | 16:21
In the March 2018 meeting of the MPI Forum, the “Persistent Collectives” proposal began the formal ratification procedure, the “Sessions” proposal took a step forward, but the “Fault Tolerance” saga took a step side-ways.
The proposal to add persistent collective operations to MPI was formally read at the March meeting, and was well-received by all those present. The first vote for this proposal will happen in June and the second vote in September. If all goes well, this addition to MPI will be announced at SC18.
Posted: 16 Apr 2018 | 16:04
Mats Simmermacher on his recent visit to Edinburgh through the HPC-Europa3 programme.
I am a theoretical chemist from the Technical University of Denmark near Copenhagen and I recently visited EPCC under the HPC-Europa3 transnational access programme. I was hosted by Dr Adam Kirrander at the University of Edinburgh's School of Chemistry.
Posted: 12 Apr 2018 | 14:34
Gina Finch of The Data Lab explains how this Scottish innovation centre creates economic benefit through data innovation.
Unlocking the value from data is the key to creating new opportunities for economic growth. Scotland is making a name for itself on the global stage as a centre for expertise in data science and a leader in the field of data innovation and exploitation. Our unique landscape of leading industry and university institutions has attracted businesses and talent alike, with industry and academia working together to innovate and create new opportunities for economic growth.
Posted: 12 Apr 2018 | 12:22
Dr Domenica Capasso was our first HPC-Europa3 visitor at EPCC but was hosted remotely at UCL from Nov 2017 to Dec 2017. She relates her experiences and research in this blog article.
I recently spent a month in London funded by the HPC-Europa3 programme and hosted by Prof. Francesco Luigi Gervasio at the Department of Chemistry at UCL. This was an exciting experience for me, primarily for my research work but it also provided me with an opportunity to visit London, a city I had never been to before. I arrived in London with interesting biological results on some potential inhibitors of the galectins class of proteins, which had been synthesized at my Institute in Naples. Galectins (Gal) are β-D-galactoside binding proteins that have important implications for many diseases including tumourigenesis, inflammatory response and autoimmune disorders. The general aim of this work is to rationally design novel inhibitors of galectins that could be used as anti-cancer and anti-inflammatory therapies.